At the news
? BEARISHIMPACT 8/10 CLUSTER filed Feb 22, 2026 at 19:00 ET
Seven corporate insiders at Vera Therapeutics, including the CEO, CFO, and other C-suite executives, collectively sold over $1.4 million in shares on February 23, 2026, all at the same price of $41.9839 per share. This represents a coordinated, open-market divestment by top leadership, with the CEO alone selling nearly $711,000 worth of stock.
- All seven transactions were open-market sales (Form 4 code 'S') on the same day at the same price.
- Total value of sales: $1,406,040.71.
- CEO Marshall Fordyce sold 16,925 shares ($710,577.51), the largest individual transaction.
- All insiders are current C-suite executives, indicating broad-based selling at the highest level of management.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access